A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

Clinical trial NCT06966453 · RECRUITING

Trial details

NCT number: NCT06966453
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Breast Neoplasms

Start date: 2025-06-30
Primary completion: 2027-10-25
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.